Hygeia Healthcare to Seek Shareholder Approval on Director Re-election, Auditor Mandate and 20% Share Issuance Capacity

Bulletin Express
05/28

Hygeia Healthcare Holdings (Hygeia Healthcare) has released its circular for the Annual General Meeting scheduled for 26 June 2026 in Hong Kong, outlining several resolutions that will be put to a shareholder vote.

Key agenda items include:

1. Board composition • Executive directors Zhu Yiwen (Chairman), Cheng Huanhuan and Jiang Hui are standing for re-election. • The Nomination Committee cites their industry experience and long-term contribution to the group in recommending their re-appointment.

2. Auditor re-appointment • Deloitte Touche Tohmatsu is proposed to continue as external auditor for the year ending 31 December 2026. • The preliminary audit fee is estimated at between RMB 2.55 million and RMB 2.65 million, subject to final scope and timing.

3. Capital management authorities • General Mandate: Directors seek authority to allot and issue new shares representing up to 20% of issued share capital (excluding treasury shares). Based on 618.50 million shares outstanding and 6.63 million treasury shares as at 26 May 2026, the mandate would allow issuance of up to 122.37 million shares. • Repurchase Mandate: The Board requests approval to buy back up to 10% of issued shares (excluding treasury shares), equivalent to 61.19 million shares. Repurchased stock may be cancelled or held as treasury shares. • Extension Mandate: Any shares repurchased under the Repurchase Mandate can be added to the General Mandate, potentially expanding issuance capacity by another 10%.

4. Recent buybacks • Over the six months to 26 May 2026, Hygeia Healthcare repurchased 6.63 million shares on the Hong Kong Stock Exchange at prices ranging from HK$10.07 to HK$14.55, all of which are currently held as treasury shares.

5. Meeting logistics and voting • The share register closes 23–26 June 2026. Shareholders on record by 22 June 2026 are entitled to attend and vote. • All resolutions will be decided by poll.

If the mandates are approved, management will have enhanced flexibility for financing, capital management and potential strategic initiatives during the coming year.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10